Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.2299
+0.0019 (0.83%)
At close: Oct 30, 2026
Elite Pharmaceuticals Market Cap
Elite Pharmaceuticals has a market cap or net worth of $247.63 million as of October 30, 2026. It is the 19,227th most valuable company in the world and the 3,387th biggest in the United States. Its market cap has decreased by 61.82% in one year.
Market Cap
247.63M
Enterprise Value
214.27M
Revenue
141.01M
Global Rank
Country Rank
#3,387 United States
PE Ratio
5.24
ChartMarket Cap Chart
Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 247.63M, an increase of 2,486.19%. That is a compound annual growth rate of 12.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 247.63M | -52.99% |
| Dec 31, 2025 | 526.74M | -8.88% |
| Dec 31, 2024 | 578.04M | 306.60% |
| Dec 29, 2023 | 142.16M | 374.74% |
| Dec 30, 2022 | 29.95M | -10.40% |
| Dec 31, 2021 | 33.42M | -36.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 369.14M |
| Sofgen Pharma | 59.82M |
| Cyphaira | 46.87M |
| Raphael Pharmaceutical | 30.47M |
| High Sierra Technologies | 28.98M |
| Earth Science Tech | 27.32M |
| Bio Essence | 23.68M |
| MariMed | 21.36M |